Ameritas Investment Partners’s Fortress Biotech FBIO Stock Holding History

Ameritas Investment Partners’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-342	Closed	-$7K	–	3121
2022 Q1	$7K	Hold	342	–	–	﹤0.01%	2890
2021 Q4	$13K	Hold	342	–	–	﹤0.01%	2818
2021 Q3	$17K	Hold	342	–	–	﹤0.01%	2772
2021 Q2	$18K	Hold	342	–	–	﹤0.01%	2784
2021 Q1	$18K	Hold	342	–	–	﹤0.01%	2604
2020 Q4	$16K	Hold	342	–	–	﹤0.01%	2575
2020 Q3	$21K	Hold	342	–	–	﹤0.01%	2348
2020 Q2	$14K	Buy	+342	New	+$12.7K	﹤0.01%	2535
2019 Q2	–	Sell	-177	Closed	-$5K	–	3066
2019 Q1	$5K	Hold	177	–	–	﹤0.01%	2852
2018 Q4	$2K	Hold	177	–	–	﹤0.01%	2948
2018 Q3	$4K	Hold	177	–	–	﹤0.01%	2965
2018 Q2	$8K	Hold	177	–	–	﹤0.01%	2885
2018 Q1	$12K	Hold	177	–	–	﹤0.01%	2656
2017 Q4	$11K	Hold	177	–	–	﹤0.01%	2710
2017 Q3	$12K	Hold	177	–	–	﹤0.01%	2694
2017 Q2	$13K	Hold	177	–	–	﹤0.01%	2698
2017 Q1	$10K	Buy	+177	New	+$7.92K	﹤0.01%	2691

Other funds holding FBIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SAM

Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Ameritas Investment Partners's FBIO Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Fortress Biotech (FBIO) in Q2 2022, closing a stake of 342 shares — an estimated $7K sold.

Ameritas Investment Partners first reported a position in FBIO in Q1 2017 and held it in 17 quarters. The position peaked at $21K in Q3 2020. 66 funds tracked by Wall St. Rank hold FBIO as of Q2 2022.

Ameritas Investment Partners reported no remaining Fortress Biotech position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 342 Fortress Biotech shares in Q2 2022, an estimated $7K.
Ameritas Investment Partners first reported a position in Fortress Biotech in Q1 2017 and held it in 17 quarters.
Ameritas Investment Partners's Fortress Biotech position peaked at $21K in Q3 2020.
66 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.